Nitin Barman, MD

Clinical Focus

• Cardiomyopathy
• Chest Pain
• ECG / EKG
• Echocardiogram
• Endocarditis
• Heart Disease
• Peripheral Vascular Disease
• Stroke

• Cardiomyopathy
• Chest Pain
• ECG / EKG
• Echocardiogram
• Endocarditis
• Heart Disease
• Peripheral Vascular Disease
• Stroke

Locations

Physician Office

440 West 114th Street, 2nd Floor, Suite 220, New York, NY, 10025

212-523-1094

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:9

Article:39

Review Article:4

Comment/Debate:2

Letter:2

Editorial:2

Recent Artifacts

• Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project
• Correction to: Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events? (Current Atherosclerosis Reports, (2022), 24, 9, (731-744), 10.1007/s11883-022-01049-z)
• Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?
• Coronary plaque vulnerability in statin-treated patients with elevated LDL-C and hs-CRP: optical coherence tomography study
• Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris
• Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents
• Relationship between hemoglobin A1C and characteristics of plaque vulnerability in stable coronary disease: an optical coherence tomography study
• Rotational Atherectomy for the Management of Undilatable In-Stent Restenosis with Single or Multiple Stent Layers
• Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry
• Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Barman during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.